Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

OCX

Oncocyte (OCX)

Oncocyte Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:OCX
DateTimeSourceHeadlineSymbolCompany
09/01/202508:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OCXOncocyte Corporation
09/01/202500:30GlobeNewswire Inc.Oncocyte Appoints Dr. Paul Billings as Consulting Chief Medical OfficerNASDAQ:OCXOncocyte Corporation
07/01/202508:05GlobeNewswire Inc.Oncocyte Expands Market Opportunity for VitaGraft™ KidneyNASDAQ:OCXOncocyte Corporation
10/12/202408:05GlobeNewswire Inc.Oncocyte to Participate in “J.P. Morgan Week” and Host Investor MeetingsNASDAQ:OCXOncocyte Corporation
10/12/202400:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OCXOncocyte Corporation
05/12/202408:15GlobeNewswire Inc.Oncocyte Demonstrates Potential for Liquid Biopsy of Brain Tumors in New StudyNASDAQ:OCXOncocyte Corporation
03/12/202408:05GlobeNewswire Inc.Oncocyte dd-cfDNA Assay Detects Kidney Transplant Rejection 11+ Months Ahead of Standard Protocols, New Study Affirms NASDAQ:OCXOncocyte Corporation
13/11/202408:08Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OCXOncocyte Corporation
13/11/202408:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OCXOncocyte Corporation
13/11/202408:05GlobeNewswire Inc.Oncocyte Reports Commercial Launch Progress; On Track to Sign 20 Transplant Centers by End of 2025NASDAQ:OCXOncocyte Corporation
07/11/202408:45GlobeNewswire Inc.Oncocyte To Announce Third Quarter 2024 Financial Results on Nov. 12NASDAQ:OCXOncocyte Corporation
23/10/202407:12Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:OCXOncocyte Corporation
22/10/202415:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:OCXOncocyte Corporation
19/10/202407:55Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:OCXOncocyte Corporation
17/10/202408:16Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:OCXOncocyte Corporation
17/10/202407:15GlobeNewswire Inc.Oncocyte Announces Participation in the LD Micro Main Event XVII Conference in Los AngelesNASDAQ:OCXOncocyte Corporation
16/10/202407:22Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OCXOncocyte Corporation
16/10/202407:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OCXOncocyte Corporation
09/10/202407:05Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:OCXOncocyte Corporation
08/10/202423:30GlobeNewswire Inc.Oncocyte’s DetermaIO Immuno-Oncology Assay Predicts Response to Atezolizumab in Phase 2 Clinical TrialNASDAQ:OCXOncocyte Corporation
05/10/202409:40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OCXOncocyte Corporation
03/10/202420:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OCXOncocyte Corporation
03/10/202408:41GlobeNewswire Inc.Oncocyte Signs Leading Transplant Centers in US and GermanyNASDAQ:OCXOncocyte Corporation
03/10/202408:35GlobeNewswire Inc.Oncocyte Corporation Announces $10.2 Million Private Placement of Securities Priced At-The-Market Under Nasdaq RulesNASDAQ:OCXOncocyte Corporation
26/09/202406:09Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:OCXOncocyte Corporation
20/08/202423:00GlobeNewswire Inc.PRISM MarketView Features Oncocyte CFO Andrea S. James on Her Career and Leadership in Molecular Diagnostics TechnologyNASDAQ:OCXOncocyte Corporation
13/08/202406:10GlobeNewswire Inc.Oncocyte’s VitaGraft™ Kidney Used to Monitor Effect of Daratumumab on Anti-body Mediated Rejection in New Case Series StudyNASDAQ:OCXOncocyte Corporation
09/08/202420:37Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OCXOncocyte Corporation
09/08/202420:25Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:OCXOncocyte Corporation
09/08/202414:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:OCXOncocyte Corporation
 Showing the most relevant articles for your search:NASDAQ:OCX

Your Recent History

Delayed Upgrade Clock